FORM DEF 14A

Company

INTEGRATED BIOPHARMA INC

Filed

October 29, 2018

Period of Report

November 26, 2018

Accession Number

0001437749-18-018968

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →